EDGAR Filing Documents for 0001415889-24-002096

Form 4 - Statement of changes in beneficial ownership of securities:

SEC Accession No. 0001415889-24-002096

Filing Date

2024-01-31

Accepted

2024-01-31 19:34:33

Documents

Period of Report

2024-01-29

Document Format Files

Seq	Description	Document	Type	Size
1		form4-02012024_120227.html	4
1		form4-02012024_120227.xml	4	6138
	Complete submission text file	0001415889-24-002096.txt		7632

Mailing Address 100 CAMBRIDGEPARK DRIVE SUITE 101 CAMBRIDGE MA 02140

Business Address 100 CAMBRIDGEPARK DRIVE SUITE 101 CAMBRIDGE MA 02140 617-655-6580

Vor Biopharma Inc. (Issuer) CIK: 0001817229 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O VOR BIOPHARMA INC. 100 CAMBRIDGEPARK DRIVE, SUITE 400 CAMBRIDGE MA 02140

Business Address

Jorgensen Nathan D. (Reporting) CIK: 0001842523 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39979 | Film No.: 24584573